Nitrofurantoin BE study [Regulatives / Guidelines]

posted by Dr_Dan  – Germany, 2015-08-31 20:19 (3594 d 19:57 ago) – Posting: # 15369
Views: 11,538

Dear PJS
Tmax is a secondary endpoint and undergoes only descriptive statistics.
Don´t try to answer questions nobody asked. So keep the study protocol as simple as it needs to be and if a authority raises questions regarding tmax you can still make up your mind. Without knowing the study outcome it is useless to discuss whether differences are clinically relevant and/or statistically significant.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,678 registered users;
72 visitors (0 registered, 72 guests [including 40 identified bots]).
Forum time: 16:16 CEST (Europe/Vienna)

Half the harm that is done in this world
Is due to people who want to feel important.    T. S. Eliot

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5